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INTRODUCTION 
Morphoea is a benign disorder characterized by localized thickening of 
the skin with no known aetiological factors. Although the skin disorder 
resembles systemic scleroderma there are no internal organ involvement. 
Morphoea is more commonly found in females and it has a characteristic 
morphology which differs in early and late stage. There are varying clinical 
types. All have characteristic distribution across the age groups. Morphoea may 
cause a lot of cosmetic problems which is very distressing to the patients. 
Sometimes it may cause growth retardations, deformity, contractures and 
disfigurement. There have been rare occurrence of pain, oedema, arthritis, 
colicky abdominal pain, visual disturbances and neurological problems in 
patients of morphoea. There are also interesting serological associations in 
morphoea. 
The interesting fact about morphoea is that it resolves on its own even 
without treatment. So far no conclusive evidence regarding its etiopathogenisis 
has been proposed in spite of the advancements in the field of medicine and 
technology. This disease, with such peculiar manifestations has kindled the 
interest of dermatologist from time immemorial. Several eminent 
dermatologists have contributed to the knowledge of morphoea. 
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REVIEW OF LITRATURE 
Morphoea is localized scleroderma caused by vascular sclerosis 
resulting in increased collagen deposition in the dermis and sometimes in 
deeper structures also1. 
The word morphoea is derived from Greek mythological character 
“Morph” who could change his body at will2. Erasmus Wilson is first credited 
for using the word to describe this lesion which he considered to be areas of 
vestiges of true leprosy3. Later Morphoea came to be used synonymously with 
localized scleroderma.   
Morphoea has varied clinical presentations. There are also several 
classifications of the clinical types. The latest classification proposed by 
Peterson et al is as follows4. 
PLAQUE TYPE OR CIRCUMSCRIBED TYPE 
           MORPHOEA EN PLAQUE  
KELOIDAL  
BULLOUS   
NODULAR  
GUTTATE /LICHEN SCLEROSUS ET ATROPHICUS 
ATRPHODERMAOF PIERINI AND PASINI 
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LINEAR TYPE 
LINEAR CLASSICAL 
EN COUP DE SABRE 
PARRY ROMBERG SYNDROME 
DEEP MORPHOEA 
SUBCUTANEOUS MORPHOEA 
MORPHOEA PROFUNDUS 
EOSINOPHILIC FASCIITIS 
PANSCLEROTIC MORPHOEA 
GENERALIZED MORPHOEA 
EPIDEMIOLOGY OF MORPHOEA 
Incidence of morphoea is more in females.5 The sex ratio is 3:15. Whites 
are more susceptible.5 Age group in which it is more common is 20 to 40 years, 
but it has been reported in a 1year old child and a 70 year old patient also. 
Morphoea is rare in children. Incidence below 10 years is 1.5% and below 20 
years is 7.2%.5 There are exceptions to this pattern. Linear morphoea has an 
incidence of 20% before the age of 10 years and 75% before the age 20 years 
.The plaque type of morphoea occurs much later in life. Only 10 % occur 
before 10 years and 75 % occurs between 20 and 40 years. Generalized 
morphoea has 80% occurrence between 11 and 50 years.5  
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The onset of morphoea is slow and insidious. The duration of morphoea 
is very variable, ranging from 3 to 25 years. The average is 3 to 5 years. 
morphoea is a self limiting disease. Therefore no conclusive studies on 
treatment are available.5 
Morphoea may be associated with various other abnormalities like 
atrophy of fat, muscles, periostium and bones.6 Vascular anomalies of the brain, 
mesentery, and kidney under lying the lesion have also been reported7. 
Most serious complications include the disturbances in bone growth 
under lying the lesion. Linear morphoea on limbs can give rise to limb length 
discrepancy and subsequent alteration in gait and height. Claw hand, hammer 
toes and fixed contracture of joints may also occur8. 
In a study conducted in sixty eight patients with linear morphoea 47% of 
them had spina bifida occulta in the radiological examination of the spine5. 
Sacralization of lumbar vertebra, presence of six lumbar segments, 
prolongation of transverse arches, scoliosis, rudimentary ribs, atrophic clavicle, 
shortened ulna, torticolis, kyphosis and contracted pelvis were some of the 
other bony anomalies reported.1 Melorheostosis was seen along bones under 
lying linear morphoea.43 In a rare study Prasad et al showed morphoea was 
associated with bone cyst.10      
In a study conducted by Christianson on 235 patients showed that 44% 
of them reported with arthralgia and pain lateralized to site of lesion on the 
extremities5. In another study conducted by Singhsen et al showed 10% of 
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children had arthritis at a site distant to the lesion on the affected side before 
the occurrence of lesion.6 
Raynaud’s phenomenon was reported in 8 out of 191 patients by 
Christianson’s study.5 An interesting feature that has been reported is unilateral 
Raynaud’s on side of the lesion.11 Emotional instability, anxiety, 
psychoneurosis, and seizures were also reported in the same study.5 The same 
study also showed 31 patients had migraine and 21 patients had colicky 
abdominal pain and infact 20 of these patients under went appendicectomy 
with no relief. 
Vascular and pigmented nevi, Becker’s melanosis and café au lait 
macules have been reported in few patients of morphoea.5 Other autoimmune 
conditions like alopecia areata, vitiligo135, icthyosis, pigmentation, nail 
dystrophy, hirsutism, carpal tunnel syndrome, absent pectoralis major, biliary 
cirrhosis and nephrotic syndrome, were some of the other features reported.9 
Rarely bullous pemphigoid and subcorneal pustulosis have also been reported 
in few cases of morphoea.12 
A rare occurrence of entrapment neuropathy due to constriction by 
sclerosing process in subcutaneous tissue and associated hypertrichosis on 
lesions has been reported in a patient of linear morphoea.13. 
Blood investigations revealed eosinophilia in both active and quiescent 
lesions.14. 
Elevated immunoglobulins IgG and IgM have been demonstrated by a 
study conducted by Signsen et al.6 In this, 8 out of 11 children had elevated 
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IgG and IgM. The same study also showed elevated ANA in most of patients 
with linear morphoea and also in children. He also showed that  incidence of  
rheumatoid factor was more in children.6. Winkleman’s study of 77 patients, 
showed that direct immunofluorence was positive in 35.8% of the cases.15 
VARIOUS TYPES MORPHOEA 
MORPHOEA EN PLAQUE: 
This the most common type of morphoea encountered. The skin is 
usually smooth, shiny, thickened, and faintly purplish or mauve coloured, or 
rarely waxy.16 The border is lilac coloured, well defined and circumscribed and 
the maximum diameter of the plaque may reach 30cm. Older lesions loose their 
original colour and become ivory coloured. The surface may sometimes be 
nodular. The hair is usually absent and there is decreased sweating.17There may 
also be loss of sensation due to the thickening of skin. The shape of the plaques 
may be circular, oval or irregular. There may be associated 
hypertrichosis.13They may be single or multiple or bilateral but are usually 
asymmetrical. The usual sites of occurrence of these lesions are the face, limbs, 
trunk and genitalia. They are less commonly found on axilla, perineum and 
nipples.17 Sometimes vesicles, bullae, telengectasia and haemorrhages may also 
be seen on the lesion.18 
The onset is usually insidious and sometimes rapid with associated 
oedema and erythema.17 Sometimes pigmentation may precede the appearance 
of lesion.5 Rarely pain may occur before the onset of lesions. Migraine or 
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colicky abdominal pain may be associated with lesions occurring on the face 
and abdomen respectively..5 
KELOIDAL MORPHOEA:  
This is a rare variant of morphoea. This resembles a keloid and it shows 
greater depth of inflammation, but limited to dermis.19 There is increased 
fibrosis and collagen deposits. This type of morphoea is mostly seen associated 
with systemic scleroderma. 
NODULAR MORPHOEA 
These can occur along with plaque type of morphoea. The surface is 
extremely nodular.20. 
BULLOUS TYPE 
Blisters may be seen in morphoea. This may be due to lymphatic 
dilatations or vascular sclerosis causing obstructions. Eosinophils capable of 
releasing major basic proteins causes subepidermal lysis and produces bullous 
lesons.22. Similar condition may also be seen in Lichen sclerosis et atrophicus. 
GUTTATE MORPHOEA (LICHEN SCLEROSUS ET 
ATROPHICUS/WHITE SPOT DISEASE)    
Guttate means rain drops. Since these lesions are also small like rain 
drops, chalky white and size varying from 1 to 10 mm these are called guttate 
morphoea. It is a very superficial type of morphoea .These lesions also have a 
well defined lilac coloured border and are seen commonly on trunk, chest, 
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neck, shoulder and extremities. Multiple lesions can be seen on the same 
person.28 
As per the classification of Peterson4, Lichen sclerosus et atrophicus is  
also considered to be type of guttate morphoea. Bizzero in his study also 
considers it to be a type of guttate morphoea.23 Certain authors like K.G. 
Bergstorm consider it to be different because of early development of 
epidermal atrophy and follicular dellings and variations in the histopathology. 
LICHEN SCLEROSUS ET ATROPHICUS: 
The lesions are porcelain white and have follicular dellings ( widened 
pilosebacious orifices) on them. They have specific HLApredispsition.24, 25 
Female related HLA includes : 
MHC I - HLA -B40, HLA -A29, HLA -B44. 
MHC II  - DQ7, DQ8, DQ9.                              
Males related HLA includes : 
- DR11, DR 12, DQ7   
Skin is atrophied and numerous lesions are seen on trunk, limbs and 
genitalia.23. Number of autoimmune disease are associated with Lichen 
sclerosis et atrophicus.26. Borrelial infection have been implicated in 
development of these lesions.90 
These lesions may also follow the Blasckho’s line. Lichenification may 
be seen surrounding the lesion due to frequent rubbing. Occasional 
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telengectasia, purpura, or bulla may be seen on the lesion. In later stages, they 
may become wrinkled and depressed. Scarring alopecia may occur on the 
scalp.28 Involvement of superior oblique muscle of the eye may give rise to 
diplopia.29. 
Anogenital lesion in women and men may occur at 45 to 60 years of 
age. Rarely female children may also have anogenital lesions. Hormonal 
influence may cause of such lesions.86 Constant friction on these surfaces may 
give rise to raw areas which may later heal to produce flat and glistening 
lesions. Patients usually complain of soreness and dyspareunia. A late 
complication may be resorption of labia, vulva, and clitoris leading to 
narrowing of vaginal introitus. Normal pregnancy and delivery have occurred 
despite this problem.30The male counterpart of this disease is called balanitis 
xerotica obliterans23 which presents with recurrent balanitis phimosis and 
painful erection. 
ATRPHODERMA OF PIERINI AND PASINI 
This is a primary abortive form of morphoea in which indurations fails 
to occur.31. It is an uncommon superficial form of localised morphoea in which 
there is an oval, hyper pigmented or slate grey atrophic plaque on the trunk. 
The plaques may be multiple and the centre is usually depressed and the border 
is described as typically being cliff-drop like.32. Some authors consider it to be 
an optical effect because of the difference in colour.33 It occurs much earlier in 
life around 10 to 20 years of age and has a protracted course. It also lacks the 
typical violacious border. It may coexist with other types of  morphoea, 
suggesting that this could have resulted from transformation of these lesions.35 
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Another peculiar feature of this morphoea is that, atrophy occurs much before 
sclerosis.36 Borrelia burgdorferi has also been implicated in the development of 
this lesion..90 
LINEAR MORPHOEA (SYN. CLASSICAL LINEAR MORPHOEA) 
Localised scleroderma occurs in linear bands in this condition. They are 
usually unilateral or rarely bilateral. The extremities are usually affected and 
lower limbs are much more commonly affected. These linear lesions may also 
occur on anterior aspect of thorax, thighs and buttocks. Homolateral lesions 
involving one arm and same side leg have also been reported. Rarely one half 
of the body may be affected.37. 
These lesions usually lack the usual violacious ring but they may be 
seen in the advancing boarders. They may also follow the lines of Blaschko.38. 
These distributions along lines of Blaschko shows that the tendency to develop 
scleroderma is predetermined during embryogenesis with formation of clones 
of vulnerable cells which on appropriate trigger may transform to develop full 
blown lesion.39. 
Patients usually complain of pain, arthralgia or oedema before the onset 
of the lesions.5The underlying bones and muscles may be involved in 20% of 
cases leading on to severe growth disturbance and limb length discrepancy. 
When these lesions cross a joint it can give rise to contractures.40 On 
radiological examination, the underlying involved bone may have a 
characteristic picture of wax flowing out of the candle due to cortical 
hyperostosis.41 This peculiar condition is called melorheostosis. This is 
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considered to be developmental anomaly. A sclerotome147 supplied by a spinal 
nerve may be affected in this condition This is a painful condition seen mainly 
in children and presenting with asymmetrical contractures and thickening of the 
overlying skin.42 Any surgical correction may further worsen the condition. 
Rarely linear scleroderma may be associated with overlying 
hypertrichosis.44.  Ulcerated dystrophic calcinosis45 and nodular morphoea46 
may also be seen on linear morphoea. Sometimes bands47 of lesions occur 
circumferentially around limbs, fingers or breasts, resembling an ainhum.48,50, 
The tissues distal to these bands may be oedematous and depigmented.49 
Fibrosis may spare areas with in a linear morphoea producing skip lesion. 
Linear morphoea of lower limbs is more commonly associated with spina 
bifida occulta.5 
FRONTOPARIETAL MORPHOEA: (SYN. EN COUP DE SABRE) 
En coup de sabre in French means a strike with a sword. Atrophy of skin 
is usually present and the skin over the affected area is usually contracted and 
firm in the early stages. Later an ivory coloured sclerotic plaque develops and 
there may be rarely overlying telengectasia and hyperpigmentation of border. 
Later a depressed groove appears on the frontoparietal region, extending on to 
the scalp. In the scalp there is alopecia which in some cases may be preceded 
by bleaching of hair.54The groove may extend further down on to the cheeks, 
nose, upper lip and gums. In severe case it may involve the chin and neck also. 
It may affect the gingiva and jaws also leading to alteration in arrangement, 
spacing and direction of teeth.52 Tongue may be atrophied or grooved. There 
may be atrophy of one half of the face leading on to facial asymmetry.54 
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Rarely frontoparietal lesions may be bilateral, trilinear or may follow 
Blaschko’s lines.53 There may be associated morphoea lesions on other sites of 
the body or there may be total atrophy of one side of the body either 
homolateral or contralateral or rarely both sides.56,57 The underlying bone can 
also get affected. There may be EEG abnormalities showing dysarrythmias 
under the affected site.28 Variety of ocular lesions  like enophthalmous, lid 
ptosis, extroccular muscle weakness, iris atrophy , heterochromia iris , atrophy 
of fundus ,loss of eye lashes (along the line of involvement ) and eye lid 
oedema may be the presenting feature.58,59 Rarely ossification may occur in 
later stages.57 
PARRY ROMBERG SYNDROME 
Hemiatrophy of Parry Romberg is similar to frontoparietal morphoea but 
there is usually no cutaneous sclerosis. It usually begins as hyperpigmentation 
on the face. The skin is less bound down to the deeper structures and it is 
usually seen along the distribution of the trigeminal nerve.56. 
DEEP MORPHOEA 
MORPHOEA PROFUNDUS 
Whittaker et al described this morphoea, in which all layers of the skin 
are involved.61They appear as solitary fibrotic plaque on shoulders, back, neck, 
or paraspinal areas. The skin is invariably hyperpigmented .Osteoma cutis 
develops very often in these lesions.62 The skin is bound down and borders are 
usually ill defined. They have a cobble stone or pseudocellulite appearance. 
The “groove sign” (a depression along the course of a vein between muscle 
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groups) may be evident.28. In subcutaneous morphoea, the subcutaneous plane 
alone is involved and there no signs of inflammation on the skin. Flexions 
contractures are more common in this type.21 
DISABLING PANSCLEROTIC MORPHOEA OF CHILDREN 
This a rare forms of morphoea. Dermis, fat, fascia, muscles and even 
bones are sclerosed before the age of 14 years. It may develop from linear 
morphoea or de novo. Trunk, extremities, scalp, and face may be involved .The 
finger, soles and toes are exceptionally spared.63 The patient may walk on tip 
toes due to contractures of Achilles tendon. The onset is usually acute and there 
may be associated arthralgia and stiffness. The intense pain may be due to 
involvement of cutaneous nerves.64 Oesophageal, pulmonary and periodontal 
changes may be seen. Flexion contractures, osteoporosis and bone changes are 
some of the common complications seen. 
Electromyogram is usually abnormal. Histopathological changes in 
muscle may be seen .Creatinine phosphokinase level is normal. Serological 
investigation shows elevate ESR, eosinophilia and hypergammaglobulinemia. 
Treatment with PUVA and cyclosporine have been useful. With out treatment 
this condition is progressive and occasionally fatal. 
GENERALIZED MORPHOEA (SYN. GENERALIZED 
SCLERODERMA) 
In this condition there is generalized sclerosis of the skin. There is no 
systemic disturbance. It occurs between 30 to 40 years of age.65A rare 
incidence has been reported below 11yrs and above 50 years.5 Females are 
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more commonly affected more than men. The sex ratio is 3:1.5 On set is usually 
insidious. Individual plaques look like localized morphoea. It usually begins in 
the trunk. The hands may resemble the tumid phase of systemic scleroderma. 
Spindling of fingers may be seen. Flexion contractures have also been 
reported5. Rarely the whole body from head to foot may be involved.66 There 
may be dyspnoea when chest wall is involved. Respiratory failure has been 
reported due to inter costal muscles involvement. The face may be shiny and 
brown, and expressionless due to indurations of the under lying skin and there 
may be restricted mouth opening. Raynaud’s phenomenon have also been 
reported in few cases.5 Whitlows following trauma have been reported.67Non 
pitting oedema may precede the development of morphoea. Bullous, keloidal or 
nodular type may coexist with generalized morphoea. Acral myofibromas may 
occur in few cases.67 Overall hyperpigmentation may be the presenting 
symptom.5The skin lesions of generalised morphoea may be superimposed by 
keratosis or calcinosis.65 
Contracture of joints, thinning of limb and soreness may be the 
presenting complaints in acute phase of the disease. Joint pains were reported 
in 50% of cases5. Rheumatoid arthritis, polymyositis and sick sinus syndrome 
may coexist along with this condition.68 Sometimes intractable pain, infection 
and atrophy of the limbs may occur in this condition. Squamous cell 
carcinomas have occurred in long standing case of morphoea.1  
Generalised morphoea may also coexist with lichen sclerosus et 
atrophicus.133 Subcutaneous involvement of lesions occurring in generalised 
morphoea is more inflammatory than superficial morphoea. Rarely 
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subcutaneous involvement in generalised morphoea may occur with systemic 
eosinophilia.114 
EOSINOPHILIC FASCIITIS: (SYN. SCHULMAN’S SYNDROME)  
Although it is a distinct entity some authors consider it to be a variant of 
morphoea.69. It forms one end of spectrum of linear morphoea and the other end 
of systemic scleroderma. It may be associated with other connective tissue 
disorders. It occurs both in children and adults. Males are more commonly 
affected. There is acute pain before the onset of the lesions, which is followed 
by swelling and tenderness of the distal parts of the limbs and later there is 
induration.70There is limitations of movement of feet and hands. Occasionally 
the lesions can occur on face or abdomen and there may be superficial 
blistering or haemorrhage on them. Trauma or strenuous exercise is considered 
to precipitate this condition. There is no Raynaud’s phenomenon, internal 
organ involvement or history of previous infections in this condition. 
Eosinophilic fasciitis like syndrome have also been reported after 
ingestion of L-Tryptophan.71 In addition to the usual feature of muscle 
weakness, muscle enzymes are also elevated. Enhanced type I procollagen gene 
expression in the skin has been demonstrated.72  In another similar condition 
called  eosinophilia-myalgia syndrome, there may be dyspnoea, oedema, 
arthralgia and rashes in addition to the above features.73. This condition is also 
precipitated by ingestion of L-Tryptophan.74  
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Histopathological examination of eosinophilic fasciitis may be similar to 
morphoea. There may be raised ANA titre, hypergammaglobulinemia and 
eosinophilia.75This condition also resolves on its own.72. 
ASSOCIATIONS OF MORPHOEA 
Although morphoea is a localised condition with out any systemic 
involvement, there are many interesting associations with morphoea. 
Arthralgia,5unilateral Raynaud’s11 migraine and colicky abdominal pain5 have 
been reported. Spina bifida was found in some of the cases of linear 
morphoea.5,96,101 Sacralization of lumbar vertebra, presence of six lumbar 
vertebrae, prolongation of transverse arches, kypohosis, scoliosis, lumbar 
intervertebral disc prolapse, rudimentary clavicle, torticolis, atrophic clavicle, 
absent pectoralis muscle, contracted pelvis, shortened ulna and deformities of 
feet and toes were other bony defects described.5 Warty vascular pigmented 
naevi, usually on the same side of morphoea, lichen planus146 café au lait spots, 
alopecia areata, vitiligo,135 generalised icthyosis, pigmentation, dystrophy of 
nails and hirsutism have also been reported in few patients.1 Children may be 
intellectually precocious.5 Variants of morphoea occurring later in life may also 
be associated with tissue calcification. Hair loss and beaking of nose were also 
seen in few studies.9 Bullous pemphigoid, subcorneal pustulosis and primary 
biliary cirrhosis have also been reported as associations.12 Localised morphoea 
and Lichen sclerosus et atrophicus have occurred in same patients.136  
No systemic changes were found in morphoea except for oesophageal 
changes in 27% of cases.5 systemic lupus erythematosis107, progressive 
scleroderma, dermatomyosites110, carpal tunnel syndrome15, myasthenia gravis, 
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nephritis, elastosis perforans serpiginosa, discoid lupus erythematosis, 
rheumatoid arthritis146 and mixed connective tissue disorder were other 
autoimmune disorders seen in morphoea.108 Silicon implants into breast for 
augmentation may also cause morphoea.104 Morphoea like features have also 
followed carcinoid syndrome.105  There is no relation between internal 
malignancy and morphoea. Squamous cell carcinoma1 have occurred in long 
standing cases morphoea. 
ETIOPATHOGENISIS 
Pathogenesis of morphoea is still a mystery. Various studies have been 
conducted and numerous theories have been put forward to explain the 
evolution of morphoea. The basic fact is that there are increased fibroblasts, 
and increased production of collagen. 
There is always a triggering factor for production of sclerosis. A 
vascular injury may be the primary insult promoting migration of mononuclear 
cells across the damaged endothelial cells. The endothelial cells promote 
increased production of platelet derived growth factors and their receptors. 
There is increased production of Transforming growth factors-β (TGF-
β), which may increase connective tissues growth factor76 (CTGF) gene 
expressions and promote fibrosis. There are also increased production of 
interleukin 2 (IL 2)77 receptors, IL6 receptors, CD4, CD8, CD28, CD30, TNF-
α78, soluble vascular cell adhesion molecules (VCAM-1), E selectin79 and 
endothelial cell antibodies. All these promote fibrosis. Such changes have also 
  
18
been reported in graft versus host disease and idiopathic thrombocytopenic 
purpura.80  
A possible pathogenic role of fibrillin –1 in localised sceleroderma has 
been demonstrated by isolation fibrillin –1 antibody82,83  in the serum of 
patients. The progenitor cell antigen CD3484 identified in a subpopulation of 
dendritic cells are decreased in localised scleroderma, proving that a loss of 
immunomodulations may result in pathogenesis of morphoea. In 
melorheostosis of bone of, TGF-β is increased causing proliferation of 
periosteal fibroblasts.77 
Connective tissue growth factor (CTGF) has the ability to induce TGF-B 
and ultra microscopy and RNA analysis shows that CTGF m RNA is increased 
in lesional cells. TGF-β & CTGF form a loop that induce and sustain fibroblast 
proliferation and extracellular matrix production.83 Antibody to U1RNP has 
also been implicated in development of morphoea.81 
ETIOLOGICAL THEORYS 
Various theories and precipitating factors have been proposed for the 
development of morphoea. Few of them are as follows. 
GENETICS 
There is increased incidence of morphoea in family members of 
patients.85 Monozygotic twins have had morphoea. So far HLA predisposition 
has not been elucidated. There are increased organ specific antibodies in 
relatives of patients.86 
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TRAUMA 
Trauma preceding the development of lesions have been reported in 
several studies.87 Trauma may trigger vascular sclerosis and lead on to 
cutaneous sclerosis.88 Surgical trauma has caused morphoea following surgery 
for atriovenous fistula and rhinophyma.89 
VACCINATION 
Vaccination for B.C.G,93 varicella zoster94 and tetanus90 have triggered 
morphoea. 
Injection 
Injection vitamin K91 has produced lesions around the hip girdle. The 
characteristic distribution is called gun-belt and holster sign.91 In several other 
studies shows injections whose nature was unknown have also precipitated 
morphoea probably due to trauma. 
HORMONAL CAUSES 
Pregnancy has precipitated morphoea in many females.86 Extract of 
pratharmone injections in rats have produced sclerodermatous changes and 
calcium deposits in skin and decalcification of bones.93 Lichen sclerosis et 
atrophicans in prepubertal girls have resolved after puberty. Improvement of 
lesions in menopausal women after hormonal therapy further supports this 
view.86 
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METABOLIC CAUSES 
Phenylketoneuria has been implicated in development of morphoea.92 
Low phenylalanine diet has resulted in resolutions of these lesions. Diabetes 
mellitus has also produced scleroderma like changes.  
INFECTION 
Several infections have been implicated in development of morphoea. 
Important among them is Borrelia burgdorferi.94 Polymerised chain reactions 
have detected DNA of these bacteria in lesional skin. Generalized morphoea 
has followed measels.95 
DRUGS 
Several drugs have been implicated in development of morphoea. They 
include penicillamine98, bromocriptine99, hydroxytryptophan109, carbidopa104, 
pentazocine,96 docetaxal100 and bleomycin.97 Isolated limb perfusion with 
melphalan104 have caused morphoea in few patients on limbs103. Among this 
penicillamine have been used as a therapy for morphoea and has induced 
morphoea in few patients. There has been spontaneous improvement after 
stopping these drugs. Valproic acid used in treatment of seizure has also 
triggered morphoea.104 
RADIOTHERAPY 
Morphoea at the sites of radiotherapy have been reported. Breast cancer 
treated with chest wall irradiation has later on lead to development morphoea in 
the same region and also in the calf region.105a 
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MISCELLANEOUS CAUSES 
Exposure to epoxy resins, vinyl chloride, organic solvents and pesticides 
have produced scleroderma like changes. 
NEURAL THEORY 
Linear morphoea of lower limbs have been associated spina bifida 
occulta.5 In a study conducted by Rubin et al 17.3% to 33% patients had 
spinabifida occulta in lumbosacral spine.101 This defect could have damaged the 
spinal cord, by trauma or adhesion of cauda equina to the defect may give rise 
to trophic changes of lower limbs resembling the changes seen on morphoea. 
This view supports the theory that nerve damage is the important cause of 
development of morphoea.102 
Segmental morphoea or linear morphoea that usually follows the course 
of peripheral nerves further supports this theory that injury of these nerves 
could have triggered morphoea. The prolongation of sensory chronaxie in 
systemic scleroderma further strengths this theory.105 
IMMUNOLOGICAL THEORY 
Other autoimmune conditions have also been associated with 
morphoea.86This association suggests that morphoea could also be an 
autoimmune disorder. Pernicious anaemia, hypothyroidism, thyrotoxicosis, 
alopecia aereata, diabetes and vitiligo135 have been reported to occur in 
association with morphoea.108 Antithyroid antibodies108, ANA6 and antiparietal 
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antibodies108 have also been isolated in considerable cases of morphoea. 
Morphoea like lesion have been reported in graft versus host reactions.80 
Deposition of immunoreactive substances in lesional skin further 
strengthens this theory. Winkle man et al has demonstrated positive direct 
immunofluorence in 24 out of 77 patients( 35.8%) in his study.15  
There are many studies that show morphoea has followed or coexisted 
with other autoimmune diseases like systemic lupus erythematosus111,112 and 
progressive systemic sclerosus.110 
Presence of hypergammaglobulinemia6, positive rheumatoid factor6 and 
L.E110 cells are additional supports for immunological theory. 
INVESTIGATIONS 
Anaemia is seen in several patients of morphoea.28. ESR is raised in 
many patients with active morphoea.137 Eosinophilia (>400cells/cumm) is also 
present in many of the patients.14 Antihistone antibodies 115 were positive in 
25% of plaque type of morphoea and 32% of linear morphoea. Anti single 
stranded antibodies to DNA116 are frequently found, in generalized morphoea 
(75%), linear morphoea (53%) and plaque type (27.3%). Rheumatoid factor117 
is especially raised in children with linear morphoea.6 Hereditary deficiency of 
C2 has been demonstrated by Hulsman in study.118 Organ specific antibodies 
were also found in relatives of morphoea.86 Idiopathic thrombocytopenia were 
present in many patients, which improved with corticosteroid therapy were 
recorded119. Antinuclear28 antibodies were also positive in 40% of patients and 
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showed both homogenous and speckled pattern. Procollagen peptide I and 
III121, antibody to topoisomerase II28 and antibody to Zn/Cu super oxide 
dismutase28have been recently reported to be raised in patients of morphoea.  
Severe hypocomplimentemia, eosinophilia, raised ESR, and anti DNA 
are useful in judgement of activity of morphoea.120 The progression  to 
systemic scleroderma is assessed by presence of Anti ku antibodies.123 
ULTRASONOGRAM 
Ultrasound scanning of the lesion with 20MH B mode pulse  measures 
the thickness of the morphoea122and is also useful in assessing the prognosis. 
RADIOLOGICAL EXAMINATION 
Radiological examination of skull and limbs shows underlying growth 
arrests. A peculiar condition called melorheostosis41 of bones showing cortical 
hyperostosis can be made out. Shortening of limbs, indurations of skull and 
other bony abnormalities like sacralization of lumbar vertebra, contracted 
pelvis, rib anomaly, atrophy of clavicle, spina bifida occulta, shortened ulna, 
kypohosis, and scoliosis and bone cysts can be made out.1,5  
MRI OF BRAIN 
Frontoparietal morphoea may show cortical atrophy, ventricular 
dilatation, calcification of leptomenninges or anomalies of intracranial 
vasculature.28  
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MRI IN EOSINOPHILIC FASCIITIS 
This shows oedema of subcutaneous tissue and increased signal 
intensity on T2- waited images and contrast enhancement of the facial planes.28. 
ELECTROENCEPHALOGRAM 
Dysarrythmias in EEG underlying the lesional skin have been 
reported.24in frontoparietal morphoea. 
DIRECT IMMUNOFLUORENCE  
This shows IgM, IgG, andC3 deposits were seen around the blood 
vessels of the sclerosed skin.15  
HISTOPATHOLOGY 
It is difficult to differentiate the different clinical types of morphoea by 
histopathology but the difference in depth of involvement can be appreciated. 
Severity can be graded according to the depth of involvement.  
Based on the evolution of morphoea they can be graded as early, 
intermediate and late. 
EARLY STAGE 
Biopsy of the specimen in early inflammatory stage especially from 
violacious border shows dense lymphocytic inflammatory infiltrate in  dermis 
and around blood vessels. Collagen bundle are only slightly thickened. In later 
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stages vascular changes are seen in subcutaneous tissue also. Endothelial 
swelling are seen in the vessal walls.125  
INTERMEDIATE STAGE 
A much more pronounced inflammatory infiltrate is seen in dermis and 
subcutaneous tissue extending upwards to surround the eccrine glands. 
Trabeculae subdividing the subcutaneous fat are also thickened due  to 
deposition of newly formed collagen. Collagen is usually composed of fine, 
wavy fibres which are arranged in bundles and stain faintly with eosin-
haematoxylin stain.124 
LATE STAGE 
Biopsy from the centre of the plaque or from an old plaque shows  no 
inflammatory infiltrate in dermis except for few in subcutaneous tissue .The 
epidermis may be atrophied and there is loss of rete ridges. The collagen in 
reticular dermis appears thickened, closely packed, hypocellular and stain more 
deeply with eosin than normal skin. In papillary dermis the collagen is more 
homogenous. 
The eccrine glands are markedly atrophic and are conspicuous by 
absence of adipocytes surrounding them and are surrounded by newly formed 
collagen. There are very few blood vessels seen with in the sclerotic area. The 
walls of vessels are also fibrotic and the lumen is narrowed. Special elastic 
stains show thick elastic fibres lying parallel to the collagen strands. Similar 
process is also seen in subcutaneous tissue.124 
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DEEP MORPHOEA 
The fascia shows increased fibrotic process as seen in subcutaneous 
tissue and muscle fibres appear vacuolated and separated from one another by 
oedema and there is focal collection of inflammatory cells.125 
BULLOUS MORPHOEA 
This is a rare type of morphoea. There is a sub epidermal separation due 
to oedema because of lymphatic obstruction. 
ATROPHODERMA OF PASINI AND PEIRINI 
Histopathological changes are minimal, mild and non-specific. There is 
only minimal thickening of collagen bundles and scattered inflammatory 
infiltrate. Older lesions show no inflammatory infiltrate but only thickened 
collagen tightly packed in deeper layers of dermis. Indurated area show 
homogenous, hyalinized, hypertrophic collagen. The lesions are usually present 
in the back. The normal collagen in the back is usually thick. Therefore for 
comparison sake either bit of normal skin from same side or from the opposite 
side has to be included in biopsy.126 
EIOSINOPHILIC FASCIITIS 
A deep wedge shaped biopsy from a lesion shows thickened fascia 
which appears homogenous and permeated by mononuclear cells. In some 
cases infiltrate is predominantly eosinophils.28The under lying myofibrils in the 
skeletal muscles shows degeneration and severe inflammation with a increased 
component of eosinophils and focal scarring.  
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The adipose tissue shows no significant changes except for fibrous septa 
separating fat lobules which are thicker, paler, homogenous and hyalinized.  
Sometimes the collagen in lower reticular dermis and subcutaneous tissue also 
appears pale and later they may get horizontally oriented merging with the 
fascia.127 
LICHEN SCLEROSUS ET ATROPHICUS 
Epidermis is atrophic with follicular hyperkeratosis. The basal layer of 
cells shows hydropic degeneration.129The stratum malpighii also shows 
atrophy. Rete ridges are completely absent in most of the lesions. Appearance 
of keratotic plugging is associated with disappearance of appendageal 
structures. Keratotic plugging is also absent in mucosal lesions.130 There is also 
mild inflammatory infiltrates in the middle of the dermis. There is pronounced 
oedema and homogenization of the collagen in upper dermis.131The 
collagenous fibres also appear swollen, glassy and contain only few nuclei. 
They stain poorly with eosin stain and elastic fibres are very sparsely 
present.132 
ELECTRON MICROSCOPY 
Endothelium of blood vessel shows vacuolizasation. There is also 
reduplication of the basement membrane. Mononuclear cells, pericytes and 
fibroblasts show enlarged endoplasmic reticulum which confirms their 
increased activity. Perivascular inflammatory infiltrate precedes the stage of 
fibrosis. There is increased synthesis of collagen with smaller diameter of 50 
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nm or less. The normal diameter is 70 to 140nm. The ratio of Type I & Type III 
collagen is unaltered.133 
HISTOCHEMICAL STUDY 
There is excessive production of ground substance and fine collagen 
fibres. There is increased amount of PAS positive diastase resistant material in 
areas of homogenization of collagen.    The glycosaminoglycons show 
alteration in structure. Chemical analysis shows increased hexosamines and 
hexoses bound to collagen fibres. Sugars attached to the collagen give the 
homogenous appearance in eosin- haematoxylin stain.134. 
TREATMENT 
 There is no specific treatment for morphoea since it resolves on its own. 
Various topical, intralesional and systemic therapies have been tried. Some of 
the topical application includes steroids,138calcipotriol138 and topical 
photodynamic therapy.139  
Intralesional steroids138 have also been tried.  Some of the systemic 
therapies tried includes PUVA,140 methotrexate,141 grisiofulvin,142 phenytoin,143 
doxycyclin,138 etretinate,138 chloroquine,138 pencillamine,98 steroids144 vitamin 
E146 and cyclosporine.145   
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AIMS OF THE STUDY 
1 To study the incidence of Morphoea in Government General Hospital,   
Chennai during the period of two  years between September 2004 and          
September 2006 
2. To study the incidence of various types of Morphoea. 
3. To study the sex wise distribution. 
4. To study the age wise distribution. 
5. To study the commonest site of lesions. 
6. To study the main presenting complaints. 
7. To study the precipitating factors. 
8. To study the relevant serological abnormalities. 
9. To study the associated autoimmune disorders. 
10. To study the other associated anomalies. 
11. To correlate the Histopathological findings with various types of 
morphoea. 
12. To study the incidence of morphoea in relatives.  
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MATERIALS  AND  METHODS 
 All the patients attending the outpatient department of Government 
General Hospital Chennai during the period between September 2004 and 
September 2006 were screened and patients with morphology suggestive of 
morphoea were enrolled in the study. There were forty one patients who had 
morphology similar to that of morphoea. A detailed history as given in the 
proforma was elicited. Various presenting complaints like loss of sensation, 
hair and sweating over the patch and other problems like contractures, 
shortening, head ache, joint pains and seizures were also recorded. Biopsy was 
done on all patients. All patients whose biopsy was similar to that of morphoea 
was subjected to various other investigations. Total count, differential count, 
haemoglobin, erythrocyte sedimentation rate, absolute eosiniphil count, blood 
sugar, blood urea, urine albumin, urine sugar, liver function test, Antinuclear 
antibody titer, Rheumatoid factor and  ‘C’ reactive proteins were tested. 
Radiological pictures of spine of patients with linear morphoea of the lower 
limbs were taken. Relevant radiological examination of the limbs and skull 
were also taken. Opinion of Neurologist and Ophthalmologist were obtained in 
patients of frontoparietal morphoea. All the data were compiled and inference 
drawn.   
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OBSERVATIONS AND RESULTS 
INCIDENCE  
Of total 30,000 patients attending Skin O.P Government General 
Hospital, Chennai, during the period between September 2004 and September 
2006, total number of patients with morphoea was 41. 
Incidence of morphoea was 1per 1000 or 0.14% 
TABLE - 1 
Total no. of patients attending Skin O.P in Govt. Gen. 
Hosp. (Sep 2004 to Sep 2006 ) 
30,OOO 
Total no. of patients with morphoea 41 
Incidence of morphoea  0.14 % 
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DIFFFERENT TYPES OF MORPHOEA AND THEIR                     
INCIDENCE          
Percentage of different types are as follows: 
Linear – 36% 
Plaque – 34% 
Frontoparietal –20% 
Generalized –5% 
Mixed –5% 
TABLE – 2 
S. No Clinical types No of cases 
1 Linear type 15 
2 Plaque type 14 
3 Frontoparietal 9 
4 Gen. morphoea 2 
5 Mixed (plaque and linear) 2 
 Total 41 
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AGE WISE DISTRIBUTION 
 Youngest person was 4 year old female child 
 Oldest person was 49 year old woman 
 Incidence of morphoea peaked between 10 to 25 years 
 Incidence below 10 years was 9% 
 Incidence below 20 years was 48% 
TABLE – 3 
Age in years Females Males Total 
0 - 4 0 1 1 
5 - 9 3 0 3 
10 - 14 6 2 8 
15 - 19 7 1 8 
20 - 24 3 5 8 
25 - 29 0 1 1 
30 - 34 2 0 2 
35 - 39 3 0 3 
40 - 44 0 1 1 
45 - 50 4 2 6 
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AGE WISE DISTRIBUTION OF PLAQUE TYPE 
 Incidence below 10 years was nil 
Incidence between 20 to 50 years was 34% 
 
TABLE - 4 
Age Male Female Total 
0 - 9 0 0 0 
10 - 19 1 4 6 
20 - 29 1 1 2 
30 - 39 0 3 2 
40 - 49 3 1 4 
Total 5 9 14 
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AGE WISE DISTRIBUTION OF LINEAR TYPE 
Incidence below 10 years was 2% 
Incidence below 20 years was 14% 
 
TABLE - 5 
Age Male Female Total 
0 - 9 1 0 1 
10 - 19 0 6 6 
20 - 29 2 - 2 
30 - 39 0 3 3 
40 - 49 1 2 3 
Total 4 11 15 
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AGE WISE DISTRIBUTION OF GENERALIZED TYPE 
Incidence between 11 and 50 years was 2% 
TABLE - 6 
Age Male Female Total 
0 - 9 0 0 0 
10 - 19 0 1 1 
20 - 29 0 0 0 
30 - 39 0 0 0 
0 1 1 1 
Total 0 2 2 
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AGE AND SEX WISE DISTRIBUTION FRONTOPARIETAL  
Incidence in males and females are equal 
Incidence between 10 to 30 years was 20% 
 
TABLE - 7 
Age Male Female Total 
0 - 9 0 0 0 
10 - 19 2 2 4 
20 - 29 2 2 4 
30 - 39 0 0 0 
40 - 49 0 0 0 
Total 4 4 8 
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AGE AND SEX WISE DISTRIBUTION OF MIXED TYPE 
Incidence of mixed type of morphoea was 5% 
TABLE - 8 
Age Female Male Total 
0 - 10 2 0 2 
 
DURATION OF EVOLUTION OF MORPHOEA 
  Average durations of evolution of morphoea was 2 to 3 years 
TABLE – 9 
Evolution period in years No. of patients 
0 - 1 3 
1 - 2 2 
2 - 3 1 
3 - 4 29 
4 - 5 3 
5 - 6 3 
                                  
  
39
 
SEX WISE DISTRIBUTION OF DIFFERENT TYPES OF 
MORPHOEA 
 Incidence of morphoea was more in females 
The female to male ratio was 2 : 1 
TABLE - 10 
S.No Clinical types Female Male Total 
1 Linear type 11 4 15 
2 Plaque type 9 5 14 
3 Frontoparietal 4 4 8 
4 Gen. Morphoea 2 0 2 
5 Mixed 2 0 2 
6 Total 28 13 41 
 
  
40
SYMPTOMS 
The most common presenting complaint was disfigurement - 63% 
TABLE - 11 
Complaints No. of patients 
DISFIGUREMENT 26 
  SENSATION 4 
PAIN 4 
HEAD-ACHE 1 
OEDEMA 1 
ARTHRITIS 2 
SHORTENNING 1 
CONTRACTURES 3 
HEMIATROPHY 1 
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ASSOCIATED CONDITIONS 
Associated disorders seen were as follows ;  
TABLE - 12 
Associated features No. of patients 
MUCOSAL LICHEN PLANUS 1 
VITILIGO 1 
LICHEN SCLEROSUS ATROPHICUS 1 
CAFÉ AU LAIT MACULES 1 
RHEUMATOID ARTHRITIS 1 
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NUMBER OF LESIONS SEEN IN MOST PATIENTS 
The maximum number of lesion encountered in a patient – 6 
The number of patients with single lesions were 33 – (80% ) 
TABLE -13 
No. of lesions No. of patients 
1 LESION 33 
2      “ 2 
3       “ 2 
4       “ 2 
5        “ 0 
6        “ 1 
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SITE COMMONLY INVOLVED 
The most common site was lower limbs – 39% 
Bilateral involvement of lower limbs was present in 2 patients 
The next most commonly affected area was head 
TABLE - 14 
FACE & SCALP 8 
CHEST 2 
ABDOMEN 6 
BACK 1 
UPPER LIMBS 4 
LOWER LIMBS 16 
BIL. LOWER LIMBS 2 
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EOSINOPHILIA 
Percentage of patients with eosinophilia was 66% 
TABLE – 15 
Eosinophils > 400/µl No. of Patients 
TOTAL NO. OF PATIENTS 
INVESTIGATED 
41 
TOTAL NO. OF PATIENTS WITH ↑ 
EOSINOPHILS 
27 
PERCENTAGE OF PATIENTS WITH ↑ 
EIOSINOPHILS 
66% 
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PATIENTS WITH RAISED ESR 
Percentage of patients with raised ESR was 41% 
TABLE – 16 
(ESR > 30mm/hr) No. of Patients 
TOTAL NO. OF PATIENTS WITH  
INVESTIGATED 
41 
TOTAL NO. OF PATIENTS WITH ↑ ESR 17 
PERCENTAGE OF PATIENTS WITH ↑ ESR  41% 
                     
HISTOPATHOLOGICAL EXAMINATION 
Most of the patients showed feature of late morphoea 
Percentage of patients with late morphoea was 80% 
TABLE - 17 
NO. OF PATIENTS WITH EARLY MORPHOEA 8 
NO. OF PATIENTS WITH LATE MORPHOEA 33 
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ANA POSITIVITY IN DIFFERENT TYPES OF MORPHOEA 
( 1/10 ++,1/40 ++) 
Percentage of patients with ANA positivity was 24% 
Percentage of ANA positivity in patients with linear morphoea was 14% 
 
TABLE - 18 
S.No. Different types of morphoea ANA positivity 
1 LINEAR MORPHOEA 6 
2 GEN. MORPHOEA 1 
3 PLAQUE 2 
5 FRONTOPARIETAL 1 
 TOTAL 10 
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RHEUMATOID FACTOR  
Rheumatoid factor was positive in one patient – 24 units 
C REACTIVE PROTEINS 
C reactive proteins was positive in one patient – 320 ng/dl                                                
ANA PATTERN 
The most common ANA pattern seen was homogenous type 
TABLE - 19 
HOMOGENOUS PATTERN 9 
SPECKELED PATTERN 1 
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PRECIPITATING FACTORS 
Trauma, organophosphorus compounds and injections have precipitated 
morphoea in following patients. Trauma (physical and iatrogenic factors) can 
precipitate morphoea. 
TABLE - 20 
TRAUMA 2 
ORGANOPHOSPHORUS COMPOUNDS 2 
INJECTIONS 2 
 
RADIOLOGICAL ABNORMALITIES 
Relevant radiological examination of patients with limb shortening,  
frontoparietal and linear morphoea were undertaken. Radiological examination 
of spine was carried out in all patients with linear morphoea. 
The percentage of linear morphoea with spina bifida occulta was 6%. 
TABLE - 21 
TOTAL NO. OF PATIENTS WITH LINEAR MORPHOEA 
SCREENED 
15 
NO. OF PATIENTS WITH RADIOLOGICAL 
ABNORMALITY ( SPINA BIFIDA OCCULTA ) 
1 
PERCENTAGE OF PATIENTS WITH ABNORMALITY 6% 
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DISCUSSION 
In this study of 41 patients the incidence of morphoea was found to be 1 
in 1,000. (Tab.1) Incidence of various clinical types of Morphoea are as 
follows: (Tab. 2) 
Plaque-35% 
Linear-36% 
Generalaized-5% 
Mixed-5% 
Frontoparietal-19% 
A study by Christianson H.B. of 235 cases showed an incidence of 35% 
of plaque type, and 49% of linear type and 19% of generalized morphoea.5 
The youngest person in this study was a 4 year old female child and the 
most aged person was a 49 year old woman. (Tab.3). In Christianson’s study 
the youngest person was a 1 year old child and the oldest was a 76 year old 
person.  In this study, the maximum number of cases was between 10 to 25 
years of age, whereas in Christianson’s study, the peak incidence was between 
20 to 40 years. In this study the incidence of morphoea below 10 years was 9% 
and below20 years was 48%. In Christianson’s study incidence below 10 years 
was 1.5% and below 20years was 7.2%. 
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In this study incidence of plaque type below 10 years was nil and 
between 20 to 50 years was 34%. (Tab.4). In Christianson’s study incidence of 
the same below 10 years was 10% and between 20 to 50 years was 75 %. 
  In this study incidence of linear type below 10 years was 2% and below 
20 years was 7.2%. (Tab.5). Christianson’s study showed 10% incidence below 
10 years and 75% below 20 years. 
In this study incidence of generalized morphoea between 11 and 50 year 
were 2% (Tab.6) whereas Christianson’s study showed 80 %. 
Incidence of frontoparietal morphoea peaked between 10 and 30 years 
of age. (Tab.7). Maximum incidence of mixed(linear and plaque) type of 
morphoea was below 10 years of age. (Tab.8).  
The average duration of evolution in this study was 2 to 3 years. (Tab.9).                         
In Christianson’s study, the average time was 3 to 5 years. 
The incidence of morphoea in this study was more in females. The sex 
ratio between females to males was 2:1. The sex ratio in Christianson’s study 
was 3:1 male. (Tab.10). 
The most common complaint of the patients was disfigurement. (63 %) 
(Tab.11). In Christianson’s study 44% of patients presented with pain and 
arthralgia whereas in this study pain in near by joints was the presenting 
complaints in only two (5%) of the patients. One of them had hemiatrophy on 
the right side of the trunk. Two patients had flexion contractures of the joints. 
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Four persons presented with loss of sensation. There was oedema preceding the 
appearance of lesion in one patient. There was shortening of 1cm of the lower 
limbs of one child due to soft tissue contracture. One patient with frontoparietal 
morphoea complained of head ache and ophthalmologist diagnosed him of 
having myopia and he was prescribed spectacles. Despite wearing spectacles he 
continued to have head ache and after which he did not report for follow up. 
Head ache may be an association of morphoea.146 
Associated disorders seen in patients in this study includes mucosal 
lichen planus, vitiligo, rheumatoid arthritis, café au lait macules and lichen 
sclerosus et atrophicus. (Tab. 12). These associations have also been reported 
in various other studies.  Finklestein E, reported a case of vitiligo with 
morphoea.135 Winkleman reported a case of lichen sclerosus with morphoea.136 
Rheumatoid arthritis and lichen planus has also occurred frequently with 
morphoea.146 
The maximum number of lesions in one person was six. (Tab.13). Most 
patients however had only single lesions. (80%) 
The most commonly affected site was lower limbs. (39%)  (Tab.14). 
Two of the patients showed bilateral involvement of lower limbs. The next 
common site was head and third most commonly affected area was the 
abdomen and chest. 
The serological investigations showed eosinophilia and raised ESR. 
Eosinophilia was present in 66% of patients. (Tab.15). Raised ESR was seen in 
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41% of patients. (Tab.16) A study conducted by Flagana showed similar 
findings.137. 
Histopathological examination of biopsy from patients showed features 
of late morphoea in 33 patients (80%) and early morphoea in the rest (20%) of 
the patients. (Tab. 17). In late morphoea there was no inflammatory infiltrates 
and the epidermis was atrophied with loss of rete ridges. The collagen in the 
dermis was thick, hypertrophied, homogenised, hyalinized and hypocellular. 
There was also high uptake of eccrine glands. The glands were also atrophic 
and adipocytes were absent. In early morphoea, inflammatory infiltrates was 
seen extending up to the eccrine glands and also around perivascular spaces. 
Endothelial swelling was also seen in blood vessals. Collagen bundles were 
only slightly thickened. 
ANA positivity was 24% in this study.(Tab-18). Signsen et al in his 
study showed 40% positivity. He also showed that ANA positivity was more in 
children and in patients with linear morphoea. In this study ANA positivity in 
linear morphoea was 14%. 
Rheumatoid factor was also positive in one patient of morphoea and 
incidentally he was also having rheumatoid arthritis. He was also positive for C 
reactive proteins.(320ng/dl). Singsen et al in his study has proved similar 
association.   
Among the 10 patients with ANA positivity, homogenous pattern was 
seen in 9 patients (90%) one showed speckled pattern of deposits. (Tab.18).  
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There was history of trauma preceding lesions in 2 patients and there 
was history of administration of injection(nature unknown) in 2 of patients 
preceding the appearance of lesions. This shows that trauma could be 
precipitating factor for development of morphoea as reported in 
literature.87There were 2 farmers in this study with increased exposure to 
organophosphorus compounds. (Tab. 20). No definite conclusions regarding 
this factor could be drawn from the above history because of the small sample 
size. 
One child with linear morphoea showed spina bifida occulta on 
radiological examination of the spine. (6%) (Tab.21) Christianson showed 47% 
of association of spina bifida occulta with linear morphoea. Rubin et al also 
showed a similar association.101 
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CONCLUSION 
* The incidence of Morphoea in Government General Hospital during the     
period of September 2004 to September 2006 was 1 in 1000. 
* The incidence of various types of Morphoea were as follows  
PLAQUE TYPE   34% 
 LINEAR TYPE   36% 
 GENERALIZED TYPE   5% 
 MIXED TYPE   5% 
 FRONTOPARIETAL TYPE 20% 
* The female to male sex ratio was 2:1. 
* The maximum number of patients were in the age groups of 10 to 
25years of age. 
* Linear morphoea was more commonly seen in lower limbs. 
* The main complaints of patients was disfigurement. 
* One of the precipitating factors was found to be trauma. 
* Serological investigations showed eosinophilia in 66% of patients. 
* ESR was raised in 41% of patients. 
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* ANA was positive in 24% of patients. 
* Homogenous pattern of ANA was most commonly seen. 
* The associated autoimmune disorders seen were lichen planus, vitiligo      
and rheumatoid arthritis. 
* The other associated anomalies seen were spina bifida occulta, café au 
lait macules, lichen sclerosus atrophicus. 
* Histopathological study showed compatibility with late morphoea in      
most of the patients. 
* There was no incidence of morphoea in patient’s relatives.  
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KEY TO MASTER CHART 
 
 
F   - FEMALE    
 
M   - MALE    
  
Ass   - Associated 
 
Abd   - Abdomen   
 
RLL   - Right upper limb   
 
LLL   - Left upper limb     
 
LT Head  - Left Head 
 
RT Head  - Right Head 
 
SP BOC  - Spina bifida occulta  
 
½ Body  - Hemiatrophy    
 
HPE   - Histopathological  examination  
 
HB%   - Haemoglobin 
 
CRP   - C reactive proteins 
  
PPPT Factors  -  Precipitating factors 
 
COS   - Cosmetic problem 
 
Dec Sen  - Decreased sensation. 
 
Contr   - Contrature 
 
Loss of hai  - Loss of Hair 
 
P   - Plaque type of morphoea 
 
LM   - Linear type of morphoea 
 
FP   - Frontoparietal morphoea 
 
GM   - Generalized morphoea 
 
LSA   -  Lichen sclerosus et atrophicus  
  
LP   - Lichen Planus 
PROFORMA 
Case No.: 
Complaints:                       
Duration:    Onset:        Insidious    Rapid  
No of lesions: 
 
SITE                                      
      
Head:    Face:    Scalp  :    
Limbs:  Upper:    Lower:       
Trunk:  Chest:     Buttocks:        Back :  
Abdomen:  
 
ASSOCIATED COMPLAINTS: 
       
Disfigurement:  Contracture:   Pain:                      Arthritis:      
Raynaud’s phenomenon:  Loss of sensation:   Decreased sweating: 
Loss of hair:     Disparity in size of limbs:  
Headache:     Seizures:  
 
SYSTEMIC COMPLAINTS:  
  
Difficulty in swallowing :  Breathlessness: 
Dyspnoea :     Palpitations:  
Past history:  
Trauma :  
Exanthematous fever:  
Pencillamine:  
Injections Vitamin K or any other injection 
B.C.G Vaccination: 
Drugs: 
Pencillamine:   Bleomysin :    Cocaine:  
Pentazocine:    Bromocriptine :   Docetaxel:                    
Antiepilepticdrugs: 
 
OCCUPATIONAL EXPOSURE:        
 
Vinyl chloride (laundering):   benzene (dying):  
Toluene:      Epoxy resins (film making):  
Radiation exposure:    Miscellaneous:  
Silicon implants:  
Exacerbation during pregnancy:  
Metabolic disorders like D.M /Phenylketonuria: 
Treatment taken:  
Family members having similar problems:   Relation:  
GENERAL EXAMINATION:       
 
Anaemia:   Cyanosis:   Pedal oedema:              
lymphadenopathy:  
J.V.P:           
Jaundice:   Clubbing :        Purpuric spots:       
Vital signs:   P.R:  B.P:   TEMP:   R.R:  
Ocular examination:  
Lid ptosis:  Oedema:   Extra ocular muscle weakness:  
Enophthalmous:  Iris atrophy:   Heterochromia iris:  
Intraoral examination: 
Tongue:  Crowding of teeth:   Gingival atrophy:: 
 
SYSTEMIC EXAMINATION: 
 
C.V.S:   R.S:   C.N.S:   PER/ABD:  
Musculoskeletal examination: 
kyphosis/scoliosis:    Rib anomaly:  
Contracted pelvis:  
Atrophic clavicle:   Disparity of limb length:  
Absent pectoralis major:   Shortened ulna:   Atrophy of face:       
 
DERMATOLOGICAL EXAMINATION: 
Single:   Multiple   Hyper/hypo pigmented plaques:  
Hide bound:   Well circumscribed:  Border:  
Loss of hair : 
Elevated/depressed/nodular surface :                      Hypoanesthetic.  
Special feature:  
Calcinosis/telengectasia/tenderness/oedema 
/attachment to underlying Structures:  
Hair:   Nail:   Genitalia:   Palms & soles:  
 
INVESTIGATIONS: 
T.C:    D.C :   E.S.R:   Blood sugar:  
Blood. Urea:   Serum Creatinine:  
Liver function test:  
Urine albumin:   Sugar    Deposits:  
Platelet count:  X-Ray: spine:   limbs:  Skull:  
E.C.G: 
A.N.A Titre:   Rheumatoid Factor:   ‘C’. Reactive Proteins:  
H.P.E:   Early/late.                      Special features:  
 
 
OPHTHALMOLOGY OPINION:         
NEUROLOGY OPINION:           
PLAQUE TYPE OF MORPHOEA WITH LILAC 
COLOURED BORDERS 
PLAQUE TYPE OF MORPHOEA WITH 
HYPERPIGMENTATION 
A SMALL BOY WITH FRONTOPARIETAL 
MORPHOEA SHOWING ALOPECIA 
A GROOVE DEVELOPING ON THE FACE IN 
EARLY FRONTOPARIETAL MORPHOEA 
HISTOPATHOLOGY OF LATE MORPHOEA SHOWING 
HYPERTROPHIED, HOMOGENIZED AND HYLANISED COLLAGEN. 
THE SWEAT GLANDS ARE ATROPHIC, ADIPOCITES ARE ABSENT 
AND ARE SORROUNDED BY NEWLY FORMED COLLAGEN 
HISTOPATHOLOGY OF EARLY MORPHOEA SHOWING 
INFLAMMATORY INFILTERATES IN THE DERMIS. THE 
COLLAGEN IS ALSO OEDEMATOUS
LINEAR MORPHOEA ON THE THIGH 
THE SAME PERSON SHOWNG LINEAR MORPHOEA 
EXTENDING ON TO THE LEGS 
THE SAME PERSON SHOWING ATROPHY ON ONE 
SIDE OF THE CHEST 
 
LINEAR MORPHOEA ON THE LEGS PRESENTING 
WITH HYPER PIGMENTATION 
 
 
THE SAME PERSON SHOWING LESIONS EXTENDING 
ON TO THE GLUTEAL REGION 
 
A PATIENT WITH GENERALIZED MORPHOEA SHOWING 
LESIONS ON THE RIGHT SIDE OF THE CHEST 
 
LINEAR MORPHOEA CROSSING OVER THE WRIST 
PRODUCING CONTRACTURE 
WOMAN WITH GENERALIZED MORPHOEA ALSO 
HAVING ORAL LICHEN PLANUS 
 
 
 
 
A PATIENT WITH MORPHOEA ALSO HAVING 
VITILIGO 
 
LICHEN SCLEROSUS EI ATROPHICUS PRESENT IN A 
PATIENT OF MORPHOEA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
X-RAY OF SPINE SHOWING SPINA BIFIDA OCCULTA 
 
HISTOPATHOLOGY SHOWING EARLY MORPHOEA IN 
HIGHER MAGNIFICATION. PLENTY OF INFLAMMATORY 
INFILTERATES CAN BE SEEN IN THE DERMIS 
